Table 3. Syntheses of Peptide Drugs Using Piperidine and Dipropylamine as Fmoc Removal Agents.
Cpd. sequencea | Fmoc deprotection reagentb | temperature (°C) | crude yieldc(%) | crude purityd (%) | isolated yielde (%) |
---|---|---|---|---|---|
Afamelanotide | 20% PPR | 60 | 70 | 46 | 17 |
Ac-SYSNleEHfRWGKPV | 25% DPA | 60 | 45 | 50 | 10 |
Bivalirudin | 20% PPR | 60 | n.d. | 77 | 46 |
fPRPGGGGNGDFEEIPEEYL-OH | 25% DPA | 60 | n.d. | 77 | 39 |
20% PPR | 90 | 6.6 | 28 | n.d. | |
25% DPA | 90 | 4.6 | 25 | n.d. |
One-letter code for amino acids, D-amino acids in lower case. C-terminus is carboxamide for Afamelanotide and carboxyl for Bivalirudin. Ac, acetyl group; Nle, norleucine.
PPR, piperidine; DPA, dipropylamine. Percentages (%) are in v/v.
The crude product after resin cleavage was precipitated, washed, dried, lyophilized and analyzed by analytical HPLC to determine the percentage of desired product and other byproducts.
Isolated yields were calculated after preparative RP-HPLC purification according to the amount of resin and its indicated loading. n.d., not determined.